ID: ALA4866987

Max Phase: Preclinical

Molecular Formula: C13H14ClN3O3

Molecular Weight: 295.73

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncc([N+](=O)[O-])n1CCOCc1cccc(Cl)c1

Standard InChI:  InChI=1S/C13H14ClN3O3/c1-10-15-8-13(17(18)19)16(10)5-6-20-9-11-3-2-4-12(14)7-11/h2-4,7-8H,5-6,9H2,1H3

Standard InChI Key:  APOTUSGMZRAPHK-UHFFFAOYSA-N

Associated Targets(non-human)

Pancreatic alpha-amylase 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.73Molecular Weight (Monoisotopic): 295.0724AlogP: 2.97#Rotatable Bonds: 6
Polar Surface Area: 70.19Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 2.51CX LogD: 2.51
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.47Np Likeness Score: -2.12

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source